We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
677

Sector Composition

Rank Sector Weight
1 Technology 25.13%
2 Consumer Discretionary 10.52%
3 Financials 9.9%
4 Healthcare 8.91%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNO icon
1226
CNO Financial Group
CNO
$5.07B
$421K 0.01%
17,630
+10,201
+137% +$250K
MSEX icon
1227
Middlesex Water
MSEX
$1.11B
$421K 0.01%
3,503
+2,943
+526% +$313K
PVH icon
1228
PVH
PVH
$3.77B
$421K 0.01%
3,952
-3,149
-44% -$344K
IAA
1229
DELISTED
IAA, Inc. Common Stock
IAA
$421K 0.01%
8,322
+3,397
+69% +$181K
RNR icon
1230
RenaissanceRe
RNR
$13.3B
$420K 0.01%
2,480
-3,648
-60% -$571K
GTLS
1231
DELISTED
Chart Industries
GTLS
$419K 0.01%
2,627
+2,059
+363% +$364K
PHM icon
1232
Pultegroup
PHM
$24.9B
$418K 0.01%
7,319
-7,682
-51% -$394K
Z icon
1233
Zillow
Z
$8.08B
$418K 0.01%
6,545
+5,978
+1,054% +$431K
IBBQ icon
1234
Invesco NASDAQ Biotechnology ETF
IBBQ
$80.4M
$417K 0.01%
17,566
+8,182
+87% +$199K
KBR icon
1235
KBR
KBR
$4.81B
$417K 0.01%
8,742
+1,470
+20% +$64.9K
CION icon
1236
CION Investment
CION
$382M
$415K 0.01%
+31,768
New +$409K
HAE icon
1237
Haemonetics
HAE
$4.11B
$415K 0.01%
7,807
+4,328
+124% +$264K
SAGE
1238
DELISTED
Sage Therapeutics
SAGE
$415K 0.01%
9,768
+3,805
+64% +$159K
INO icon
1239
Inovio Pharmaceuticals
INO
$93M
$414K 0.01%
6,922
+1,859
+37% +$149K
AVNT icon
1240
Avient
AVNT
$4.23B
$413K 0.01%
7,390
-402
-5% -$22K
FEX icon
1241
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.63B
$413K 0.01%
4,472
-1,561
-26% -$141K
NVAX icon
1242
Novavax
NVAX
$1.34B
$412K 0.01%
2,878
+501
+21% +$86.1K
RDUS
1243
DELISTED
Radius Recycling
RDUS
$412K 0.01%
7,927
+7,196
+984% +$369K
AWI icon
1244
Armstrong World Industries
AWI
$7.68B
$411K 0.01%
3,541
-5,367
-60% -$579K
FUL icon
1245
H.B. Fuller
FUL
$3.24B
$411K 0.01%
5,075
+544
+12% +$40.2K
DVAX
1246
DELISTED
Dynavax Technologies
DVAX
$410K 0.01%
29,109
-25,334
-47% -$417K
QQMG icon
1247
Invesco ESG NASDAQ 100 ETF
QQMG
$206M
$410K 0.01%
+15,380
New +$405K
SCHB icon
1248
Schwab US Broad Market ETF
SCHB
$45.2B
$410K 0.01%
21,780
-28,176
-56% -$518K
SEF icon
1249
ProShares Short Financials
SEF
$12.9M
$410K 0.01%
8,800
+2,293
+35% +$109K
SLM icon
1250
SLM Corp
SLM
$5.22B
$410K 0.01%
20,798
-1,042
-5% -$19.1K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 677 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.